Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Grant or award Director acquired 12,006 shares (grant or award)
  2. 4 Open-market sale Director sold 2,700 shares at $9.48 ($25,593)
  3. 4 Open-market sale Director sold 6,441 shares at $9.90 ($63,779)
  4. 4 Open-market sale Director sold 6,500 shares at $9.85 ($64,052)
  5. 4 Open-market sale SVP & General Counsel sold 12,060 shares at $11.09 ($133,779)
  6. 4 Open-market sale SVP, Chief Marketing Officer sold 6,974 shares at $11.19 ($78,060)
  7. 4 Open-market sale President and CEO sold 37,096 shares at an average $11.16 ($413,959)
  8. 4 Open-market sale SVP, CFO & Treasurer sold 12,305 shares at an average $11.26 ($138,513)
  9. 4 Open-market sale SVP, Business Development sold 15,601 shares at an average $11.25 ($175,492)
  10. 4 Open-market sale President and CEO sold 96,200 shares at an average $16.25 ($1,563,623)
  11. 4 Open-market sale Chief Corp. Affairs Officer sold 16,824 shares at $16.49 ($277,394)
  12. 4 Open-market sale Director sold 19,109 shares at $16.74 ($319,976)
  13. 4 Open-market sale SVP, Chief Marketing Officer sold 3,650 shares at $15.39 ($56,190)
  14. 4 Open-market sale SVP & General Counsel sold 3,715 shares at $16.15 ($59,989)
  15. 4 Open-market sale SVP, CFO & Treasurer sold 2,130 shares at $19.24 ($40,973)
  16. 4 Open-market sale Chief Corp. Affairs Officer sold 7,250 shares at $19.69 ($142,776)
  17. 4 Open-market sale Director sold 5,000 shares at $19.42 ($97,122)
  18. 4 Open-market sale Director sold 2,075 shares at $19.34 ($40,132)
  19. 4 Grant or award Director acquired 5,000 shares (grant or award)
  20. 4 Grant or award Director acquired 5,000 shares (grant or award)

Page 6 of 29 · 579 filings